Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)-Reference-Cited by-同舟云学术

Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)

Published:2011-09 Issue:5 Volume:108 Page:682-690
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Bays Harold E.,Ballantyne Christie M.,Kastelein John J.,Isaacsohn Jonathan L.,Braeckman Rene A.,Soni Paresh N.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Fenofibrate for the treatment of type IV and V hyperlipoproteinemias: a double-blind, placebo-controlled multicenter US study;Goldberg;Clin Ther,1989

2. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications;Bays;Expert Rev Cardiovasc Ther,2008

3. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

4. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review;Balk;Atherosclerosis,2006

5. The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans;Nestel;Am J Clin Nutr,2002

Cited by 310 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review;Nutrients;2024-09-01

2. Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation;Journal of the American Heart Association;2024-07-16

3. Cardiovascular outcomes and coronary artery disease prevention secondary to icosapent ethyl: a meta-analysis of randomized clinical trials;Annals of Medicine & Surgery;2024-07-03

4. Validation of Nutritional Approaches to Modulate Cardiovascular and Diabetic Risk Factors in Patients with Hypertriglyceridemia or Prediabetes—The MoKaRi II Randomized Controlled Study;Nutrients;2024-04-24

5. Pleiotropic beneficial cardiometabolic actions of a high‐purity eicosapentaenoic acid product in high cardiovascular risk individuals;Lipids;2024-02-21